Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

Halozyme Therapeutics (HALO)

NASDAQ:HALO

HALO

Halozyme

RESEARCH TOOLSreports

Halozyme (HALO) Ratios

Compare

1,150 Followers

Halozyme Ratios

HALO's free cash flow for Q3 2025 was $0.84. For the 2025 fiscal year, HALO's free cash flow was decreased by $ and operating cash flow was $0.63. See a summary of the company’s cash flow.

Ratios	TTM	Dec 24	Dec 23	Dec 22	Dec 21
Liquidity Ratios
Current Ratio	1.59	7.80	6.64	5.65	7.91
Quick Ratio	1.37	6.78	5.50	4.88	7.45
Cash Ratio	0.50	0.83	1.05	1.79	1.01
Solvency Ratio	0.42	0.31	0.22	0.15	0.45
Operating Cash Flow Ratio	0.73	3.44	3.45	1.84	2.56
Short-Term Operating Cash Flow Coverage	0.86	0.00	0.00	18.01	3.35
Net Current Asset Value	$ -388.57M	$ -614.32M	$ -903.04M	$ -932.70M	$ 18.81M
Leverage Ratios
Debt-to-Assets Ratio	0.68	0.73	0.86	0.82	0.79
Debt-to-Equity Ratio	3.00	4.14	17.89	8.87	4.45
Debt-to-Capital Ratio	0.75	0.81	0.95	0.90	0.82
Long-Term Debt-to-Capital Ratio	0.61	0.81	0.95	0.90	0.80
Financial Leverage Ratio	4.41	5.67	20.68	10.85	5.61
Debt Service Coverage Ratio	1.01	30.04	20.53	8.87	4.26
Interest Coverage Ratio	41.53	30.48	17.99	15.79	36.66
Debt to Market Cap	0.18	0.25	0.31	0.19	0.16
Interest Debt Per Share	13.04	12.02	11.51	11.13	6.29
Net Debt to EBITDA	1.23	2.12	3.06	4.03	2.93
Profitability Margins
Gross Profit Margin	84.55%	84.30%	76.80%	78.90%	81.64%
EBIT Margin	61.45%	56.65%	44.27%	40.28%	62.24%
EBITDA Margin	71.32%	64.66%	54.50%	47.80%	58.43%
Operating Profit Margin	59.33%	54.32%	40.71%	40.53%	62.24%
Pretax Profit Margin	60.02%	54.87%	42.01%	37.71%	56.06%
Net Profit Margin	47.91%	43.74%	33.96%	30.62%	90.84%
Continuous Operations Profit Margin	47.91%	43.74%	33.96%	30.62%	90.84%
Net Income Per EBT	79.83%	79.71%	80.84%	81.20%	162.04%
EBT Per EBIT	101.16%	101.03%	103.19%	93.04%	90.07%
Return on Assets (ROA)	26.81%	21.52%	16.25%	10.98%	36.46%
Return on Equity (ROE)	141.55%	122.06%	336.00%	119.04%	204.47%
Return on Capital Employed (ROCE)	53.28%	28.66%	20.83%	15.64%	27.95%
Return on Invested Capital (ROIC)	28.10%	22.84%	16.84%	13.36%	42.40%
Return on Tangible Assets	40.90%	35.67%	33.38%	22.82%	36.45%
Earnings Yield	6.98%	7.32%	5.78%	2.60%	7.12%
Efficiency Ratios
Receivables Turnover	3.59	3.29	3.54	2.86	4.87
Payables Turnover	12.50	15.55	16.28	7.87	52.83
Inventory Turnover	1.03	1.12	1.51	1.39	1.51
Fixed Asset Turnover	17.40	13.53	11.06	8.74	50.41
Asset Turnover	0.56	0.49	0.48	0.36	0.40
Working Capital Turnover Ratio	1.68	1.29	1.34	0.93	0.94
Cash Conversion Cycle	425.53	412.22	322.79	343.75	309.68
Days of Sales Outstanding	101.62	110.89	103.09	127.77	74.90
Days of Inventory Outstanding	353.10	324.80	242.12	262.34	241.69
Days of Payables Outstanding	29.19	23.47	22.42	46.36	6.91
Operating Cycle	454.72	435.69	345.21	390.11	316.59
Cash Flow Ratios
Operating Cash Flow Per Share	5.21	3.78	2.95	1.75	2.13
Free Cash Flow Per Share	5.14	3.69	2.83	1.72	2.12
CapEx Per Share	0.07	0.08	0.12	0.04	0.01
Free Cash Flow to Operating Cash Flow	0.99	0.98	0.96	0.98	1.00
Dividend Paid and CapEx Coverage Ratio	71.09	44.79	25.41	49.92	205.52
Capital Expenditure Coverage Ratio	71.09	44.79	25.41	49.92	205.52
Operating Cash Flow Coverage Ratio	0.40	0.32	0.26	0.16	0.34
Operating Cash Flow to Sales Ratio	0.49	0.47	0.47	0.36	0.68
Free Cash Flow Yield	7.03%	7.72%	7.66%	3.02%	5.27%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	13.96	13.65	17.32	38.52	14.04
Price-to-Sales (P/S) Ratio	6.71	5.97	5.88	11.80	12.76
Price-to-Book (P/B) Ratio	16.50	16.67	58.18	45.86	28.71
Price-to-Free Cash Flow (P/FCF) Ratio	13.85	12.95	13.06	33.09	18.98
Price-to-Operating Cash Flow Ratio	13.61	12.66	12.55	32.43	18.89
Price-to-Earnings Growth (PEG) Ratio	1.53	0.21	0.39	-0.80	0.07
Price-to-Fair Value	16.50	16.67	58.18	45.86	28.71
Enterprise Value Multiple	10.64	11.35	13.84	28.71	24.76
Enterprise Value	9.66B	7.45B	6.26B	9.06B	6.41B
EV to EBITDA	10.89	11.35	13.84	28.71	24.76
EV to Sales	7.77	7.34	7.55	13.72	14.47
EV to Free Cash Flow	16.03	15.91	16.76	38.50	21.52
EV to Operating Cash Flow	15.80	15.56	16.10	37.73	21.42
Tangible Book Value Per Share	-2.23	-3.59	-6.11	-5.74	1.40
Shareholders’ Equity Per Share	4.30	2.87	0.64	1.24	1.40
Tax and Other Ratios
Effective Tax Rate	0.20	0.20	0.19	0.19	-0.62
Revenue Per Share	10.60	8.01	6.29	4.82	3.15
Net Income Per Share	5.08	3.50	2.13	1.48	2.86
Tax Burden	0.80	0.80	0.81	0.81	1.62
Interest Burden	0.98	0.97	0.95	0.94	0.90
Research & Development to Revenue	0.06	0.08	0.09	0.10	0.08
SG&A to Revenue	0.00	0.00	0.00	0.00	0.00
Stock-Based Compensation to Revenue	0.04	0.04	0.04	0.04	0.05
Income Quality	1.03	1.08	1.38	1.19	0.74

Currency in USD